Avita Medical-Nachfolgethread-AvitaTherapeutics
Seite 2 von 2 Neuester Beitrag: 26.11.21 12:00 | ||||
Eröffnet am: | 26.07.20 09:50 | von: Medical | Anzahl Beiträge: | 28 |
Neuester Beitrag: | 26.11.21 12:00 | von: Medical | Leser gesamt: | 8.393 |
Forum: | Hot-Stocks | Leser heute: | 5 | |
Bewertet mit: | ||||
Seite: < 1 | > |
Quelle:https://www.stockwatch.com/News/Item/U-z8255089-U!RCEL-20210615/U/RCEL
FDA approved expanded use of the RECELL® System in combination with meshed autografting for the treatment of all sizes of acute full-thickness thermal burn wounds for both pediatric and adult patients.............Full-Year of Fiscal 2021 Highlights............... Total net revenue increased 105% to $29.2 million compared to $14.3 million in the prior year...................... Commercial revenues increased 50% compared to the prior year....... Gross profit margin of 80% compared to 79% in the prior year
Net loss of $26.6 million, or $1.17 per share compared to a net loss of $42.0 million, or $2.07 per share, in the prior year........" ENDE Zitat
Quelle:https://www.stockwatch.com/News/Item/U-z8315923-U!RCEL-20210826/U/RCEL
First Quarter Fiscal Year 2022 Highlights..... Total revenue increased 39% to $7.0 million compared to $5.1 million in the first fiscal quarter of 2021.... Gross profit margin improved 3% to 85% compared to the first fiscal quarter of 2021.... Total operating expenses decreased 18% to $12.3 million compared to $14.9 million in the first fiscal quarter of 2021.... Net loss of $5.9 million, or $0.24 per share compared to a net loss of $10.2 million, or $0.48 per share in the first fiscal quarter of 2021.... As of September 30, 2021, the Company had $60.4 million in cash and cash equivalents and $49.5 million in short-term and long-term marketable securities, and no debt....."Ende Zitat
Source:https://www.stockwatch.com/News/Item/U-z8388525-U!RCEL-20211108/U/RCEL
Links:
https://ir.avitamedical.com/
https://www.barchart.com/stocks/quotes/RCEL/interactive-chart
https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=RCEL (buy)
https://www2.asx.com.au/markets/company/AVH
https://sec.report/Document/0001193125-21-326416/d249729dex992.htm